| Literature DB >> 30413070 |
Lili Liu1,2, Hua Zhu3, Yanchun Yan4, Peng Lv5, Wei Wu6.
Abstract
Notwithstanding the widespread use and promising clinical value of chemotherapy, the pharmacokinetics, toxicology, and mechanism of mitoxantrone remains unclear. To promote the clinical value in the treatment of human diseases and the exploration of potential subtle effects of mitoxantrone, zebrafish embryos were employed to evaluate toxicity with validated reference genes based on independent stability evaluation programs. The most stable and recommended reference gene was gapdh, followed by tubα1b, for the 48 h post fertilization (hpf) zebrafish embryo mitoxantrone test, while both eef1a1l1 and rpl13α were recommended as reference genes for the 96 hpf zebrafish embryo mitoxantrone test. With gapdh as an internal control, we analyzed the mRNA levels of representative hepatotoxicity biomarkers, including fabp10a, gclc, gsr, nqo1, cardiotoxicity biomarker erg, and neurotoxicity biomarker gfap in the 48 hpf embryo mitoxantrone test. The mRNA levels of gclc, gsr, and gfap increased significantly in 10 and 50 μg/L mitoxantrone-treated 48 hpf embryos, while the transcript levels of fabp10a decreased in a dose-dependent manner, indicating that mitoxantrone induced hepatotoxicity and neurotoxicity. Liver hematoxylin⁻eosin staining and the spontaneous movement of embryos confirmed the results. Thus, the present research suggests that mitoxantrone induces toxicity during the development of the liver and nervous system in zebrafish embryos and that fabp10a is recommended as a potential biomarker for hepatotoxicity in zebrafish embryos. Additionally, gapdh is proposed as a reference gene for the 48 hpf zebrafish embryo mitoxantrone toxicity test, while eef1a1l1 and rpl13α are proposed as that for the 96 hpf test.Entities:
Keywords: biomarker selection; mitoxantrone; reference genes; stability evaluation; toxicity evaluation; zebrafish embryos
Mesh:
Substances:
Year: 2018 PMID: 30413070 PMCID: PMC6274943 DOI: 10.3390/ijms19113516
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1The molecular structure formula of mitoxantrone [hydorehloride].
Transcript abundance and amplification efficiency of candidate reference genes.
| Gene Name | E | R2 | Mean Cq Value | Transcript Abundance |
|---|---|---|---|---|
|
| 0.941 | 0.999 | 9.44 | High transcript abundance |
|
| 0.946 | 0.999 | 19.46 | Medium transcript abundance |
|
| 1.016 | 0.998 | 20.53 | |
|
| 0.957 | 0.999 | 21.58 | |
|
| 1.016 | 0.993 | 22.69 | |
|
| 0.922 | 0.994 | 25.4 | |
|
| 1.001 | 0.993 | 25.86 | |
|
| 0.963 | 0.997 | 27.92 | Low transcript abundance |
|
| 0.972 | 0.996 | 27.97 | |
|
| 0.901 | 0.987 | 29.56 | |
|
| 0.959 | 0.984 | 31.7 |
Stability analysis of candidate reference genes in the zebrafish embryo mitoxantrone test before 48 hpf *.
| M Value * | NormFinder | geNorm | BestKeeper |
|---|---|---|---|
|
| 0.021 | 0.678 | 1.70 |
|
| 0.013 | 0.668 |
|
|
| 0.020 | 0.842 | 2.00 |
|
| 0.034 | 1.517 |
|
|
| 0.026 | 1.266 | 2.37 |
|
| 0.012 |
| 1.48 |
|
| 0.012 | 0.814 | 2.00 |
|
| 0.029 | 0.790 |
|
|
|
| 0.667 | 1.35 |
|
|
|
| 1.45 |
|
|
|
| 1.46 |
* The higher the M value, the less stable the gene. The three most stable genes were marked with the underline for each algorithm.
Stability analysis of candidate reference genes in the zebrafish embryo mitoxantrone test before 96 hpf *.
| M Value * | NormFinder | geNorm | BestKeeper |
|---|---|---|---|
|
| 0.083 | 3.910 | 1.93 |
|
| 0.008 | 1.731 | 2.05 |
|
|
| 1.578 |
|
|
| 0.004 |
|
|
|
| 0.004 |
| 1.56 |
|
| 0.034 | 2.139 | 2.62 |
|
|
|
| 1.61 |
|
|
| 1.539 | 1.56 |
|
| 0.005 | 1.666 | 1.93 |
|
| 0.009 | 1.761 | 1.74 |
|
| 0.080 | 2.948 |
|
* The higher the M value, the less stable the gene. The three most stable genes were marked with the underline for each algorithm.
Figure 2Normalization expression analysis of a set of target genes with gapdh as a reference gene. (a) The relative normalized expression levels of target genes at 48 hpf unexposed embryos comparing to 24 hpf unexposed embryos; (b) the relative normalized expression levels of target genes at 24 hpf embryos with 10 μg/L mitoxantrone treatment comparing to 24 hpf unexposed embryos; (c) the relative normalized expression levels of target genes at 48 hpf embryos with 10 μg/L mitoxantrone treatment comparing to 48 hpf unexposed embryos. Each group was conducted in triplicate (n = 3). All values are expressed as means ± standard error of the mean (SEM). * represents significant difference compared to control, p < 0.05.
Figure 3The expression analysis of classical toxicity biomarker genes in 48 hpf embryonic zebrafish exposed to mitoxantrone. Each group is conducted in triplicate (n = 3). All values are expressed as means ± standard error of the mean (SEM). * represents significant difference compared to the corresponding control (0 μg/L mitoxantrone) groups, p < 0.05.
Figure 4The hematoxylin-eosin staining microphotographs of zebrafish liver (72 hpf) exposed to gradient concentrations of mitoxantrone (×400). The zebrafish embryos exposed to 0 (a), 10 (b), 50 (c) and 100 (d) μg/L mitpxantrone were observed at 72 hpf with hematoxylin–eosin staining. The black arrow indicated the liver tissues. The scale bar indicated 50 μm.
Figure 5The numbers of spontaneous movement of zebrafish embryos (24 hpf) in 60 s. Eight embryos in each group were chosen for counted, and each group was conducted in six biological repeats (n = 48 totally in each group). All values are expressed as means ± standard error of the mean (SEM). * represents significant difference compared to control, p < 0.05.
Candidate reference genes of zebrafish embryos used in the toxicity test.
| Gene Symbol | Gene Name | Accession | Function | Primer Sequence (5′–3′) |
|---|---|---|---|---|
|
| Generic | 18S ribosomal RNA | F: cacttgtccctctaagaagttgca | |
|
| NM_131263.1 | Factor for protein translation | F: CTGGAGGCCAGCTCAAACAT | |
|
| NM_212784 | Genetic Information Processing | F: TCTGGAGGACTGTAAGAGGTATGC | |
|
| NM_181601.4 | Cytoskeletal structural protein | F: TCTGGTGATGGTGTGACCCA | |
|
| NM_001115114.1 | Catalytic enzyme in glycolytic pathway | F: GATACACGGAGCACCAGGTT | |
|
| NM_001002317.2 | Enzyme for transcription | F: CCAGATTCAGCCGCTTCAAG | |
|
| NM_194388 | Cytoskeletal structural protein | F: TGGAGCCCACTGTCATTGATG | |
|
| NM_200910 | Enzyme in tricarboxylic acid cycle | F: GAGTCTCCAATCAGTATCCAGTAGTAGA | |
|
| NM_200096.1 | Transcription factor | F: CTTACCCACCAGCAGTTTAGCAG | |
|
| NM_001024388.1 | Enzyme in heme synthesis | F: AAGAGCGTAATAGGCACCAGTTC | |
|
| NM_131163 | Beta chain of a major histocompatibility complex I molecular | F: AGGATTGTCTGCTTGGCTCTCT |
The primers sequence of toxicity genes in embryonic zebrafish.
| Gene Symbol | Gene Name | Accession | Primer Sequence (5′–3′) |
|---|---|---|---|
|
|
| NM_152960.1 | F: CCAGTGACAGAAATCCAGCA |
|
|
| NM_199277.2 | F: AAAATGTCCGGAACTGATCG |
|
|
| NM_001020554.1 | F: CAACCTTGAAAAGGGCAAAA |
|
|
| BC065622.1 | F: CTCAAGGATTTGCCTTCAGC |
|
|
| NM_131373.2 | F: CCTGACCTGTGACCTGGAAT |
|
|
| NM_212837.1 | F: CAGATGCTCCGTGTGAAAGA |